Education

Timely Topics in Transplantation

 

Timely Topics in Transplantation

 

Timely Topics in Transplantation webinars are the perfect opportunity to listen to a live presentation on a current issue and ask questions directly to the presenter. All webinars are available on demand after the live air date.

How to Resister for and View T3 Webinars - Click on the "REGISTER" or "VIEW ARCHIVE" buttons below and use the following instructions:
  • AST MEMBERS: T3 webinars are free for AST members. After clicking "REGISTER" or "VIEW ARCHIVE," simply log in with your AST username and password to register (or purchase the webinar recording) for free.
  • NON-MEMBERS: T3 webinars are $25. If you have an account on the AST website, click on "REGISTER" or "VIEW ARCHIVE" and sign in with those credentials. If you do not have an account with AST, create an account and proceed with the online registration or purchase (your account will not be an AST membership account; it is used to access AST content).

Archived Webinars

Integrated Multi-Disciplinary Model Across the Care Continuum: Current Practice Models of Advanced Practice Providers and Pharmacists in Transplantation

Wednesday, May 5, 2021 - 2:00 pm to 3:00 pm EDT

View Archive

After participating in this webinar, the attendee will be able to:

  1. Explain the evolution of pharmacy and advanced practice providers in solid organ transplant.
  2. Share current inpatient multidisciplinary practice models.
  3. Describe the various roles of pharmacists and advanced practice providers in the outpatient setting.
  4. Discuss future opportunities for transplant pharmacists and advanced practice providers.

Speakers:

  • Holli Winters, PharmD, BCPS • Specialty Practice Pharmacist, Solid Organ Transplantation, The Ohio State Wexner Medical Center, Columbus, OH
  • Gina Jamero, MSN, ACNP-BC • Lead Nurse Practitioner, Heart Transplant and Mechanical Circulatory Support Cardiology, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

Moderator:

  • Anna Frank, PA-C • Lead Advanced Practice Provider, MedStar Georgetown Transplant Institute, Washington, D.C.
- - - - -

AST would like to thank the Advanced Practice Provider Community of Practice (APP COP) and the Transplant Pharmacy Community of Practice (TxPharm COP) for recommending this topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops. The session title has been updated from "Integrated Multi-discipline Model Across the Care Continuum: A Focus on Advance Care Practice Provider- and Pharmacist-driven Service Lines" to better reflect the focus of the presentation.

Expanding the donor pool: When to approve HCV + living liver and kidney donor candidates?

Thursday, April 22, 2021 - 2:00 pm to 3:00 pm EDT

View Archive

After participating in this webinar, the attendee will be able to:

  1. Be knowledgeable of background data regarding hepatitis C (HCV) in solid organ transplant
  2. Describe relevant considerations in the assessment of potential living donors with active or prior HCV infection which may impact donor and recipient outcomes
  3. Appreciate a framework for the screening and evaluation of such donors
  4. Describe waitlist management and ethical considerations

Speakers:

  • Cameron Wolfe, MD, MBBS(Hons), MPH, FIDSA • Associate Professor of Medicine, Infectious Disease, Duke University Medical Center, Durham, NC
  • Whitney Jackson, MD • Assistant Professor, Medicine-Gastroenterology, University of Colorado Medicine, Aurora, CO
  • Roy Bloom, MD • Professor of Medicine, University of Pennsylvania Hospital, Philadelphia, PA

Moderator:

  • AnnMarie Liapakis, MD • Associate Professor of Medicine, Medical Director Living Donor Liver Transplant, Yale New Haven Transplantation Center, New Haven, CT
- - - - -

AST would like to thank the Live Donor Community of Practice (LDCOP) and the Liver and Intestinal Community of Practice (LICOP) for recommending this topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Perfusion Technologies

Wednesday, April 14, 2021 - 2:00 pm to 3:00 pm EDT

View Archive

After participating in this webinar, the attendee will be able to:

  1. Describe the evolving role of machine perfusion in the evaluation and preservation of cardiothoracic organs.
  2. Describe the evolving role of machine perfusion in the evaluation and preservation of abdominal organs.
  3. Describe the evolving role of the Organ Procurement Organization (OPO) in the coordination of the logistics involved in the use of machine perfusion.
  4. Understand at a high level who pumps, who pays, and who benefits.

Speakers:

  • Kevin Myer, MSHA • President and Chief Executive Officer, LifeGift, Houston, TX
  • Jorge Mallea, MD • Consultant, Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic Florida, Jacksonville, FL

Moderator:

  • Malcolm MacConmara, MD, MB BCh, FACS • Assistant Professor, University of Texas Southwestern Medical Center, Dallas, TX
- - - - -

AST would like to thank the Recovery and Preservation Community of Practice (RAP COP) for recommending "Perfusion Technologies" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Novel Approaches to the Assessment of Frailty

Wednesday, March 24, 2021 - 3:00 pm to 4:00 pm EDT

View Archive

After participating in this webinar, the attendee will be able to:

  1. Educate the transplant community on the current understanding of frailty both pre and post solid organ transplantation.
  2. Establish a standardized approach for the identification and treatment of frailty both pre- and post-transplantation, including:
    A) Establishing a common nomenclature for frailty within solid organ transplantation
    B) Establishing recommendations for the assessment of frailty in solid organ transplant candidates
    C) Establishing guidelines for including a frailty assessment in candidate selection

Speakers:

  • Jennifer Lai, MD, MBA • Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
  • Mara McAdams DeMarco, PhD • Associate Professor of Surgery and Epidemiology, Director of Clinical and Outcomes Research, Johns Hopkins University, Baltimore, MD
  • Evan Kransdorf, MD, PhD • Assistant Director, Heart Transplant Research and Education, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Moderator:

  • Lianne Singer, MD, FRCPC • Professor of Medicine, University Health Network, University of Toronto, Toronto, ON
- - - - -

AST would like to thank the Women's Health Community of Practice (WHCOP) for recommending "Frailty" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Performance Measures - Ensuring Meaningful Data

Wednesday, January 27, 2021 - 2:00 pm to 3:00 pm EST

View Archive

After participating in this webinar, the attendee will be able to:

  1. Identify different types of performance measures.
  2. Define components of performance measures to ensure purposeful and meaningful data.
  3. Describe how to analyze and interpret data to evaluate performance.
  4. Discuss transplant-specific performance measures and how we can use them to improve care.

Speakers:

  • Marian O’Rourke, RN, BSN, CCTC • Director, Quality, Compliance, and Outcomes Management, Miami Transplant Institute, Jackson Memorial Hospital/University of Miami, Miami, FL
  • Jesse Schold, PhD, M Stat, MEd • Director Outcomes Research, Cleveland Clinic, Cleveland, OH

Moderator:

  • Andrea Tietjen, MBA, CPA • Director of Transplant Finance, Quality and Data, Saint Barnabas Medical Center, Livingston, NJ
- - - - -

AST would like to thank the Transplant Administration & Quality Management Community of Practice (TxAQM COP) for recommending "Performance Measures - Ensuring Meaningful Data" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Optimizing Vaccination in Transplant Candidates and Recipients

Wednesday, January 13, 2021 - 2:00 pm to 3:00 pm EST

View Archive

Q&A Handout: Covering speaker responses to questions not addressed during the live session.

After participating in this webinar, the attendee will be able to:

  1. Describe implementation and optimization of vaccination in the pre- and post-transplant settings.
  2. Review current recommendations for vaccination of the transplant population.
  3. Recognize the pipeline of vaccine development that impacts transplant patients including COVID vaccines.

Speakers:

  • Michael Green, MD, MPH • Professor of Pediatrics and Surgery, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
  • Deepali Kumar, MD, MSc, FRCPC, FAST • Professor of Medicine, Transplant Centre, University Health Network, Toronto, ON

Moderator:

  • Lara Danziger-Isakov, MD, MPH • Professor of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
- - - - -

AST would like to thank the Infectious Disease Community of Practice (IDCOP) and the Pediatric Community of Practice (PCOP) for recommending "Optimizing Vaccination in Transplant Candidates and Recipients" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Biomarkers and Gene Expression Profiling in Transplantation

Thursday, December 17, 2020 - 2:00 pm to 3:00 pm EST

View Archive

For "NanoString Technologies for Intragraft Gene Expression" - after participating in this webinar, the attendee will be able to:

  1. Recognize current methodologies and clinical indications for intragraft gene expression testing.
  2. Describe new opportunities afforded by emerging FFPE-based intragraft gene expression technologies.

For "Donor-Derived Cell-Free DNA" - after participating in this webinar, the attendee will be able to:

  1. Understand the available data on the use of donor-derived cell-free DNA for solid organ transplants (kidney, pancreas, liver, heart, lung).
  2. Understand the limitations and future directions of available data on the use of donor-derived cell-free DNA for solid organ transplants.

For "Urinary Biomarkers" - after participating in this webinar, the attendee will be able to:

  1. Explain the use of urine as a surrogate for kidney allograft biopsy.
  2. Discuss strategies to develop and validate robust biomolecular markers of kidney allograft status.
  3. Describe urinary cell biomolecular markers of human kidney allograft status.

Speakers:

  • Benjamin Adam, MD, FRCPC • Assistant Professor of Pathology, University of Alberta, Edmonton, AB
  • Gaurav Gupta, MD • Associate Professor; Medical Director of Kidney Transplantation, Virginia Commonwealth University, Richmond, VA
  • Manikkam Suthanthiran, MD • Stanton Griffis Distinguished Professor of Medicine - Weill Cornell Medical College, Cornell University, New York, NY

Moderator:

  • Minnie Sarwal, MD, PhD, FRCP, DCH • Professor, Surgery; Director, Kidney-Pancreas Transplant, UCSF, San Francisco, CA
- - - - -

AST would like to thank the Community of Transplant Scientists (COTS) and the Transplant Diagnostics Community of Practice (TxDx COP) for recommending topics related to "gene expression" and "biomarkers" for the 2020-2021 T3 series. These suggestions directly contributed to the creation of the "Biomarkers and gene expression profiling in transplantation" webinar. Learn more about AST's COPs at www.myast.org/cops.

Use of Technology to Optimize Transplant Education, Manage Polypharmacy, and Increase Adherence

Wednesday, December 9, 2020 - 2:00 pm to 3:00 pm EST

View Archive

After participating in this webinar, the attendee will be able to:

  1. Describe the prevalence and impact of non-adherence in the solid organ transplant population.
  2. Review types of technology to optimize transplant education, manage polypharmacy and increase adherence.
  3. Identify technology related barriers, challenges and real-world strategies to improve use in clinical practice.

Speakers:

  • Holly Mansell, PharmD, BSP • Associate Professor of Pharmacy, University of Saskatchewan, Saskatoon, SK
  • Tiffany Kaiser, PharmD, MS, FCCP, BCPS • Associate Professor of Medicine, University of Cincinnati, Cincinnati, OH

Moderator:

  • Patricia West-Thielke, PharmD, BCPS, FAST • Director of Clinical Research, University of Illinois at Chicago, Chicago, IL
- - - - -

AST would like to thank the Transplant Pharmacy Community of Practice (TxPharm COP) for recommending "Use of Technology to Optimize Transplant Education, Manage Polypharmacy, and Increase Adherence" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Disparities in Access to Transplantation

Wednesday, November 4, 2020 - 2:00 pm to 3:00 pm EST

View Archive

After participating in this webinar, the attendee will be able to:

  1. Describe the nature of disparities in transplantation in the US
  2. Identify factors that are driving disparities in transplantation - using kidney transplantation as a case study
  3. Highlight examples of multi-level strategies to address disparities in transplantation

Speakers:

  • Tanjala Purnell, MPH, PhD • Director of Education, Johns Hopkins Center for Health Equity, Baltimore, MD
  • Larissa Myaskovsky, PhD • Professor of Internal Medicine & Director, Center for Healthcare Equity in Kidney Disease, University of New Mexico Health Sciences Center, Albuquerque, NM

Moderator:

  • Winfred Williams, Jr., MD • Associate Chief, Division of Nephrology, Associate Professor of Medicine, Harvard Medical School, Boston, MA

 

- - - - -

AST would like to thank the Psychosocial and Ethics Community of Practice (PSECOP), in conjunction with the Pediatric Community of Practice (PCOP) and Women's Health Community of Practice (WHCOP), for recommending "Disparities in Access to Transplantation" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.